Cresco Labs Inc. Logo

Cresco Labs Inc.

CRLBF

(1.2)
Stock Price

1,26 USD

-21.99% ROA

-35.86% ROE

-3.32x PER

Market Cap.

722.375.021,00 USD

111.54% DER

0% Yield

-22.65% NPM

Cresco Labs Inc. Stock Analysis

Cresco Labs Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cresco Labs Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.88x), the stock offers substantial upside potential at a bargain price.

2 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

3 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

4 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

5 ROE

The stock's ROE indicates a negative return (-37.52%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-31.09%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 DER

The stock is burdened with a heavy load of debt (107%), making it financially unstable and potentially risky for investors.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-12) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Cresco Labs Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cresco Labs Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Hold

Cresco Labs Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cresco Labs Inc. Revenue
Year Revenue Growth
1999 0
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 3.157.232 100%
2017 10.310.000 69.38%
2018 43.252.000 76.16%
2019 128.534.000 66.35%
2020 476.251.000 73.01%
2021 821.682.000 42.04%
2022 842.681.000 2.49%
2023 762.236.000 -10.55%
2023 785.022.117 2.9%
2024 737.271.916 -6.48%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cresco Labs Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1999 0
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 370.000 100%
2019 1.989.000 81.4%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cresco Labs Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1999 0
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 300.518 100%
2009 439.159 31.57%
2010 338.344 -29.8%
2011 311.558 -8.6%
2012 341.290 8.71%
2013 205.779 -65.85%
2014 49.316 -317.27%
2015 49.316 0%
2016 42.842 -15.11%
2017 44.416 3.54%
2018 29.160.000 99.85%
2019 77.147.000 62.2%
2020 160.941.000 52.07%
2021 40.343.000 -298.93%
2022 54.985.000 26.63%
2023 263.852.000 79.16%
2023 36.805.000 -616.89%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cresco Labs Inc. EBITDA
Year EBITDA Growth
1999 -213.837
2000 -304.243 29.71%
2001 -31.577 -863.49%
2002 -130.916 75.88%
2003 -181.078 27.7%
2004 -441.251 58.96%
2005 -1.555.155 71.63%
2006 117.441 1424.2%
2007 -673.657 117.43%
2008 -594.335 -13.35%
2009 -405.239 -46.66%
2010 1.802.632 122.48%
2011 -339.323 631.24%
2012 -310.269 -9.36%
2013 -154.437 -100.9%
2014 -51.093 -202.27%
2015 65.954 177.47%
2016 -33.613 296.22%
2017 -43.753 23.18%
2018 10.311.000 100.42%
2019 -17.705.000 158.24%
2020 98.324.000 118.01%
2021 132.923.000 26.03%
2022 123.472.000 -7.65%
2023 112.024.000 -10.22%
2023 134.927.861 16.97%
2024 195.247.744 30.89%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cresco Labs Inc. Gross Profit
Year Gross Profit Growth
1999 0
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 -83 100%
2015 -61 -34.43%
2016 3.157.217 100%
2017 1.152.000 -174.06%
2018 40.417.000 97.15%
2019 64.081.000 36.93%
2020 283.940.000 77.43%
2021 406.347.000 30.12%
2022 407.013.000 0.16%
2023 374.560.000 -8.66%
2023 344.023.365 -8.88%
2024 358.282.096 3.98%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cresco Labs Inc. Net Profit
Year Net Profit Growth
1999 -248.408
2000 -483.565 48.63%
2001 82.524 685.97%
2002 -14.788 658.05%
2003 -438.972 96.63%
2004 -438.250 -0.16%
2005 -1.366.448 67.93%
2006 -981.239 -39.26%
2007 -584.552 -67.86%
2008 -2.026.063 71.15%
2009 -2.910.616 30.39%
2010 -2.275.950 -27.89%
2011 -36.868 -6073.24%
2012 -361.384 89.8%
2013 -202.736 -78.25%
2014 -117.436 -72.64%
2015 47.377 347.87%
2016 -108.032 143.86%
2017 -85.354 -26.57%
2018 -1.915.000 95.54%
2019 -65.302.000 97.07%
2020 -36.562.000 -78.61%
2021 -296.834.000 87.68%
2022 -215.843.000 -37.52%
2023 -453.780.000 52.43%
2023 -178.740.865 -153.88%
2024 -217.283.176 17.74%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cresco Labs Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1999 -67
2000 -87 22.09%
2001 15 673.33%
2002 -2 1600%
2003 -44 97.67%
2004 -29 -48.28%
2005 -71 59.15%
2006 -44 -61.36%
2007 -24 -83.33%
2008 -78 69.23%
2009 -108 27.78%
2010 -77 -40.26%
2011 -1 -7600%
2012 -10 90%
2013 -6 -100%
2014 -3 -66.67%
2015 1 400%
2016 -3 133.33%
2017 -2 -50%
2018 0 0%
2019 -1 0%
2020 0 0%
2021 -1 100%
2022 -1 0%
2023 -1 100%
2023 -1 0%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cresco Labs Inc. Free Cashflow
Year Free Cashflow Growth
1999 -232.382
2000 -46.907 -395.41%
2001 -67.275 30.27%
2002 -92.828 27.53%
2003 -259.428 64.22%
2004 -1.024.069 74.67%
2005 -2.687.240 61.89%
2006 -1.135.521 -136.65%
2007 -1.077.608 -5.37%
2008 -458.665 -134.94%
2009 -361.366 -26.93%
2010 -177.720 -103.34%
2011 -219.896 19.18%
2012 34.814 731.63%
2013 5.159 -574.82%
2014 -4.682 210.19%
2015 83.507 105.61%
2016 -125.458 166.56%
2017 -4.027.084 96.88%
2018 -39.860.000 89.9%
2019 -121.315.000 67.14%
2020 -91.208.000 -33.01%
2021 -82.566.000 -10.47%
2022 -67.391.000 -22.52%
2023 40.622.000 265.9%
2023 693.489 -5757.63%
2024 10.159.489 93.17%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cresco Labs Inc. Operating Cashflow
Year Operating Cashflow Growth
1999 -170.521
2000 -46.907 -263.53%
2001 -67.275 30.27%
2002 -59.968 -12.18%
2003 -259.428 76.88%
2004 -95.225 -172.44%
2005 -326.754 70.86%
2006 -177.252 -84.34%
2007 -405.646 56.3%
2008 -100.945 -301.85%
2009 -165.747 39.1%
2010 -167.694 1.16%
2011 -216.934 22.7%
2012 34.814 723.12%
2013 5.159 -574.82%
2014 -4.682 210.19%
2015 83.507 105.61%
2016 -22.826 465.86%
2017 29.916 176.3%
2018 -9.916.000 100.3%
2019 -25.189.000 60.63%
2020 -10.831.000 -132.56%
2021 14.487.000 174.76%
2022 18.741.000 22.7%
2023 40.622.000 53.86%
2023 59.637.994 31.89%
2024 17.301.284 -244.7%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cresco Labs Inc. Capital Expenditure
Year Capital Expenditure Growth
1999 61.861
2000 0 0%
2001 0 0%
2002 32.860 100%
2003 0 0%
2004 928.844 100%
2005 2.360.486 60.65%
2006 958.269 -146.33%
2007 671.962 -42.61%
2008 357.720 -87.85%
2009 195.619 -82.87%
2010 10.026 -1851.31%
2011 2.962 -238.57%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 102.632 100%
2017 4.057.000 97.47%
2018 29.944.000 86.45%
2019 96.126.000 68.85%
2020 80.377.000 -19.59%
2021 97.053.000 17.18%
2022 86.132.000 -12.68%
2023 0 0%
2023 58.944.505 100%
2024 7.141.795 -725.35%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cresco Labs Inc. Equity
Year Equity Growth
1999 -35.306
2000 -381.010 90.73%
2001 -125.206 -204.31%
2002 12.473 1103.81%
2003 662.132 98.12%
2004 2.544.539 73.98%
2005 4.692.337 45.77%
2006 4.491.732 -4.47%
2007 6.610.359 32.05%
2008 3.402.289 -94.29%
2009 1.468.324 -131.71%
2010 -711.544 306.36%
2011 -491.949 -44.64%
2012 -754.401 34.79%
2013 -880.477 14.32%
2014 -889.177 0.98%
2015 -762.478 -16.62%
2016 -921.317 17.24%
2017 13.194.036 106.98%
2018 282.981.000 95.34%
2019 322.623.000 12.29%
2020 724.758.000 55.49%
2021 797.736.000 9.15%
2022 587.683.000 -35.74%
2023 425.876.881 -37.99%
2023 425.862.000 -0%
2024 374.453.076 -13.73%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cresco Labs Inc. Assets
Year Assets Growth
1999 478.736
2000 362.904 -31.92%
2001 336.439 -7.87%
2002 401.938 16.3%
2003 902.790 55.48%
2004 2.791.177 67.66%
2005 4.974.835 43.89%
2006 4.992.868 0.36%
2007 7.104.566 29.72%
2008 4.290.184 -65.6%
2009 2.501.143 -71.53%
2010 412.422 -506.45%
2011 232.108 -77.69%
2012 207.278 -11.98%
2013 187.570 -10.51%
2014 125.962 -48.91%
2015 111.653 -12.82%
2016 75.748 -47.4%
2017 1.838 -4021.22%
2018 318.111.000 100%
2019 616.554.000 48.41%
2020 1.333.124.000 53.75%
2021 1.780.463.000 25.12%
2022 1.583.692.000 -12.42%
2023 1.351.516.675 -17.18%
2023 1.399.153.000 3.4%
2024 1.357.846.835 -3.04%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cresco Labs Inc. Liabilities
Year Liabilities Growth
1999 514.042
2000 743.914 30.9%
2001 461.644 -61.14%
2002 389.464 -18.53%
2003 240.658 -61.83%
2004 246.637 2.42%
2005 282.498 12.69%
2006 501.135 43.63%
2007 494.207 -1.4%
2008 887.894 44.34%
2009 1.032.819 14.03%
2010 1.123.967 8.11%
2011 724.057 -55.23%
2012 961.679 24.71%
2013 1.068.047 9.96%
2014 1.015.138 -5.21%
2015 874.131 -16.13%
2016 997.065 12.33%
2017 1.065.801 6.45%
2018 35.130.000 96.97%
2019 293.931.000 88.05%
2020 608.366.000 51.69%
2021 982.727.000 38.09%
2022 996.009.000 1.33%
2023 925.639.794 -7.6%
2023 973.291.000 4.9%
2024 983.393.759 1.03%

Cresco Labs Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.18
Net Income per Share
-0.49
Price to Earning Ratio
-3.32x
Price To Sales Ratio
0.96x
POCF Ratio
6.22
PFCF Ratio
12.3
Price to Book Ratio
1.21
EV to Sales
1.71
EV Over EBITDA
7.43
EV to Operating CashFlow
14.16
EV to FreeCashFlow
21.94
Earnings Yield
-0.3
FreeCashFlow Yield
0.08
Market Cap
0,72 Bil.
Enterprise Value
1,29 Bil.
Graham Number
3.88
Graham NetNet
-2.26

Income Statement Metrics

Net Income per Share
-0.49
Income Quality
-0.53
ROE
-0.36
Return On Assets
-0.13
Return On Capital Employed
-0.02
Net Income per EBT
1.3
EBT Per Ebit
7.09
Ebit per Revenue
-0.02
Effective Tax Rate
-0.23

Margins

Sales, General, & Administrative to Revenue
0.11
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.48
Operating Profit Margin
-0.02
Pretax Profit Margin
-0.17
Net Profit Margin
-0.23

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.26
Free CashFlow per Share
0.17
Capex to Operating CashFlow
0.35
Capex to Revenue
0.04
Capex to Depreciation
0.44
Return on Invested Capital
-0.02
Return on Tangible Assets
-0.22
Days Sales Outstanding
26.32
Days Payables Outstanding
17.42
Days of Inventory on Hand
88.22
Receivables Turnover
13.87
Payables Turnover
20.96
Inventory Turnover
4.14
Capex per Share
0.09

Balance Sheet

Cash per Share
0,34
Book Value per Share
1,09
Tangible Book Value per Share
-0.61
Shareholders Equity per Share
1.36
Interest Debt per Share
1.67
Debt to Equity
1.12
Debt to Assets
0.38
Net Debt to EBITDA
3.26
Current Ratio
2
Tangible Asset Value
-0,21 Bil.
Net Current Asset Value
-0,71 Bil.
Invested Capital
1192966580
Working Capital
0,14 Bil.
Intangibles to Total Assets
0.43
Average Receivables
0,05 Bil.
Average Payables
0,02 Bil.
Average Inventory
96712809.5
Debt to Market Cap
0.72

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cresco Labs Inc. Dividends
Year Dividends Growth

Cresco Labs Inc. Profile

About Cresco Labs Inc.

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of January 27, 2022, it owned and operated 48 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.

CEO
Mr. Charles Bachtell
Employee
2.900
Address
400 West Erie Street
Chicago, 60654

Cresco Labs Inc. Executives & BODs

Cresco Labs Inc. Executives & BODs
# Name Age
1 Mr. John Schetz
General Counsel
70
2 Mr. Zach Marburger
Chief Information Officer
70
3 Ms. Angie Demchenko
Chief People Officer
70
4 Mr. Charles Bachtell
Co-Founder, Chief Executive Officer & Director
70
5 Mr. Gregory Butler
President & Chief Transformation Officer
70
6 Mr. Dennis M. Olis
Chief Financial Officer
70
7 Mr. Ty Gent
Chief Operating Officer
70
8 Mr. Jason Erkes
Chief Communications Officer
70
9 Mr. Joseph Ales
Senior Vice President of Operations
70
10 Mr. Robert M. Sampson
Co-Founder & Independent Director
70

Cresco Labs Inc. Competitors